Comments on: U.S. FDA Approves New Indications for Harvoni® and Sovaldi® in Pediatric Patients 12 Years and Older with Chronic Hepatitis C Infection

Comments on: U.S. FDA Approves New Indications for Harvoni® and Sovaldi® in Pediatric Patients 12 Years and Older with Chronic Hepatitis C Infection https://www.novumpr.nl/2017/04/07/u-s-fda-approves-new-indications-for-harvoni-and-sovaldi-in-pediatric-patients-12-years-and-older-with-chronic-hepatitis-c-infection/?utm_source=rss&utm_medium=rss&utm_campaign=u-s-fda-approves-new-indications-for-harvoni-and-sovaldi-in-pediatric-patients-12-years-and-older-with-chronic-hepatitis-c-infection NovumPR press releases Fri, 07 Apr 2017 14:18:44 +0000 hourly 1 https://wordpress.org/?v=6.8.2